SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Afaq Sarwar who wrote (3466)5/1/1998 7:07:00 PM
From: Hal  Read Replies (1) | Respond to of 3906
 
Our enemy is our friend and the product needs a name badly.
NBC news just reported on Viagra, the downside such as
side effects and contraindications. Passing out from
interaction with other medications that are common in
older patients was one. Now Viagra has brought more attention to the ED market than ever before. I think without the attention that Viagra
brought this would have been just another news release. Coke and Pepsi
Big Mac and the Whopper, Our product needs a name. People can't
relate to things without names. It needs to be a good one.
Thank you Viagra.
Hal
BuyLowSailHi



To: Afaq Sarwar who wrote (3466)5/3/1998 10:22:00 PM
From: KZAP  Read Replies (1) | Respond to of 3906
 
I think its a good time to sell!<g>
Are the news releases still helping to sell the stock from the
company? IMHO this stock is as risky as they get.
Couldn't believe the latest news.
With the way this stock trades, Wait & See can really make
someone great money. Wish I could day trade this one all the time.

Still, good luck to those who really believe.

KZAP


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News